Diagnostically untypable hepatitis C virus variants: it is time to resolve the problem.

Area of Science:

• Hepatology
• Virology
• Public Health

Background:

• Pakistan faces a substantial burden of Hepatitis C virus (HCV) infections, exceeding 10 million cases.
• Accurate HCV genotyping is crucial for effective treatment, as sustained virological response to interferon therapy is genotype-dependent.

Discussion:

• A diagnostic challenge was identified, with 15.6% of HCV patient samples being untypable using the Ohno et al. method.
• The prevalent HCV genotypes identified were 3a (68.3%), 2a (10.3%), 3b (2.6%), 1b (1.5%), 2b (1.2%), and 1a (0.5%).
• The high proportion of untypable HCV variants poses a significant issue for the Pakistani healthcare system, complicating patient management.

Key Insights:

• Hepatitis C virus genotype 3a is the predominant strain in Pakistan.
• A notable percentage of HCV samples are not amenable to current genotyping methods, impacting treatment strategies.
• Addressing diagnostic limitations is essential for improving patient outcomes and maximizing treatment efficacy.

Outlook:

• Urgent improvements are needed in Pakistan's routine diagnostic setups for HCV.
• Enhanced diagnostic capabilities will empower healthcare professionals to optimize patient treatment plans.
• Prioritizing diagnostic advancements is key to achieving higher rates of sustained virological response in HCV patients.